Aker BioMarine ASA (Public, OSL:AKBM) is a Norwegian fishing and seafood processing company. Based in Oslo, it operates three krill fishing vessels in Antartica, Argentina and the Faroe Islands.
Worldwide leader in Krill catching, procesing and marketing. The company is listed on the Oslo Stock Exchange, but controlled 83% by Aker Seafoods, controlled by the Aker Group.
Aker BioMarine has registered Superba™ as the company`s brandnames for its krill oil products for the human market and Qrill™ company’s brand name for its krill meal and krill oil products for aquaculture feed markets.
The Company has four wholly owned subsidiaries, including, Aker BioMarine Antarctic AS, Krill AS, Natural Nutrition Development AS and Natural USA Inc. Aker BioMarine ASA has also a 50% stake in O3C Nutraceuticals AS.
October 2012 - regarding the proposed merger between Aker BioMarine ASA ("AKBM"), the transferor company, and Aker Seafoods Holding AS ("AKSH") the transferee company, where the shareholders in AKBM (except AKSH) will receive consideration shares in Aker ASA ("AKER") (the "Merger"). AKBM has today, Friday 9 November 2012, held an extraordinary general meeting regarding the Merger. The proposal was approved by the general meeting.
Cluster farming helps improve tilapia production Fiji
The Secretariat of the Pacific Community has been working with the EU and the Fiji Ministry of Fisheries and Forests in assisting smallholder tilapia farmers to improve production by working together in cluster groups.
Data gaps affect pacific tuna assessment Marshall Islands
Pacific Islands Forum Fisheries Agency requests its members to properly report their fishing catches in Pacific waters to help prevent overfishing.
New fish vaccine to protect tilapia Netherlands
MSD Animal Health (known as Merck Animal Health in the US and Canada) launched a new fish vaccine as a promising measure to help protect tilapia and other fish against the biotype 1 strain ...
Copyright 1995 - 2014 Fish Info & Services Co.Ltd| All Rights Reserved. DISCLAIMER